Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals

Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, Inc., a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer health products, today announced that the companies have closed the acquisition of Innovus by Aytu. Through this combined entity, Aytu expands into the $40 billion consumer healthcare market with a portfolio of over thirty-five consumer products competing in large therapeutic categories including diabetes, men’s health, sexual wellness and respiratory health.

Read the full article: Aytu BioScience Completes Acquisition of Innovus Pharmaceuticals //

Source: https://www.accesswire.com/576776/Aytu-BioScience-Completes-Acquisition-of-Innovus-Pharmaceuticals

Scroll to Top